Intrinsic Value of S&P & Nasdaq Contact Us

Healixa Inc. EMOR OTC

Other OTC • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
24/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Healixa Inc. (EMOR) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $0.05. It has a SharesGrow Score of 22/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $702,908, +3353%/yr average growth. Net income is $756,898 (loss), growing at -258.9%/yr. Net profit margin is -107.7% (negative). Gross margin is 56.1% (+331.4 pp trend).

Balance sheet: total debt is $7M with negative equity of -$9M — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 0.02 (tight liquidity). Debt-to-assets is 2862.1%. Total assets: $228,642.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 0/100 (Fail), Moat 50/100 (Partial), Future ?/100 (Fail), Income 10/100 (Fail).

EMOR SharesGrow Score Overview

39/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 50/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Stock Chart & Stats

Market Data
52-Week Range0.01-0.07
Volume10K
Avg Volume (30D)16.83K
Market Cap$38.3M
Beta (1Y)0.06
Share Statistics
EPS (TTM)0.00
Shares Outstanding$766.68M
IPO Date2010-12-13
CEOIan Parker
Financial Highlights & Ratios
Revenue (TTM)$702.91K
Gross Profit$394.13K
EBITDA$-464.09K
Net Income$-756.9K
Operating Income$-475.13K
Total Cash$39.14K
Total Debt$6.54M
Net Debt$6.5M
Total Assets$228.64K
Price / Earnings (P/E)-50
Price / Sales (P/S)54.49
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS57387H1059

Price Chart

EMOR
Healixa Inc.  ·  Other OTC
Healthcare • Medical - Healthcare Information Services
0.01 52WK RANGE 0.07
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message